Masayoshi Kukida Selected Research

Dopamine (Intropin)

12/2015

Angiotensin II type 2 receptor signaling affects dopamine levels in the brain and prevents binge eating disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masayoshi Kukida Research Topics

Disease

4	Vascular System Injuries 01/2016 - 01/2015
3	Atherosclerosis 01/2021 - 10/2019
3	Cognitive Dysfunction 01/2018 - 04/2015
3	Vascular Remodeling 01/2016 - 01/2016
2	Abdominal Aortic Aneurysm 01/2021 - 01/2020
2	Neointima 01/2016 - 01/2016
1	Thoracic Aortic Aneurysm 10/2021
1	Aneurysm (Aneurysms) 01/2020
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2020
1	Chronic Renal Insufficiency 10/2019
1	Vascular Calcification 01/2019
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 11/2018
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2018
1	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 11/2016
1	Hypertension (High Blood Pressure) 10/2016
1	Fibrosis (Cirrhosis) 10/2016
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2016
1	Obesity 01/2016
1	Hypercholesterolemia 01/2016
1	Binge-Eating Disorder (Binge Eating Disorder) 12/2015
1	Feeding and Eating Disorders (Eating Disorder) 12/2015
1	Body Weight (Weight, Body) 12/2015
1	Stroke (Strokes) 09/2015
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 04/2015
1	Inflammation (Inflammations) 01/2015
1	Essential Hypertension 01/2015
1	Hyperhomocysteinemia 07/2014
1	Kimura Disease 01/2014
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2014
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2012

Drug/Important Bio-Agent (IBA)

5	Type 2 Angiotensin ReceptorIBA 01/2019 - 04/2015
3	Angiotensin IIIBA 01/2021 - 01/2016
3	Polyethylene (Polythene)IBA 01/2016 - 01/2016
3	compound 21IBA 01/2016 - 04/2015
2	Angiotensin Receptor AntagonistsIBA 10/2021 - 09/2015
2	AngiotensinsIBA 01/2018 - 01/2016
2	EnzymesIBA 01/2018 - 01/2016
2	Immunoglobulin G (IgG)IBA 11/2016 - 01/2014
2	AntibodiesIBA 11/2016 - 01/2014
2	OsteopontinIBA 10/2016 - 01/2016
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2016 - 01/2016
2	CytokinesIBA 01/2016 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2016
1	LigandsIBA 10/2021
1	Fibrillin-1IBA 10/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2021
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 01/2020
1	Angiotensin IIBA 01/2020
1	LDL Receptors (LDL Receptor)IBA 01/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020
1	Lipoproteins (Lipoprotein)IBA 10/2019
1	Adenine FDA LinkGeneric 01/2019
1	Phosphates (Orthophosphate)IBA 01/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	Immunoglobulin A (IgA)IBA 11/2018
1	Angiotensin-Converting Enzyme 2IBA 01/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	HDL CholesterolIBA 11/2016
1	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 11/2016
1	Interleukin-18 (Interleukin 18)IBA 10/2016
1	AldosteroneIBA 10/2016
1	SaltsIBA 10/2016
1	LipidsIBA 01/2016
1	NAD (NADH)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Superoxides (Superoxide)IBA 01/2016
1	ApolipoproteinsIBA 01/2016
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2016
1	Dopamine (Intropin)FDA LinkGeneric 12/2015
1	sacubitril and valsartan sodium hydrate drug combinationIBA 09/2015
1	azilsartanIBA 04/2015
1	Interleukin-6 (Interleukin 6)IBA 01/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015
1	HomocysteineIBA 01/2015
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 07/2014
1	Phospholipase A2 ReceptorsIBA 01/2014
1	mizoribineIBA 01/2012
1	Inosine Monophosphate (IMP)IBA 01/2012
1	Oxidoreductases (Dehydrogenase)IBA 01/2012
1	Prednisolone (Predate)FDA LinkGeneric 01/2012

Therapy/Procedure

1	Therapeutics 11/2018
1	Protein-Restricted Diet (Diet, Protein Restricted) 01/2016